http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-202220661-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3be2429bd1a83fd492acffa31808839c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2021-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1d58b2069828569bf6aff536b6f2e6d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd5e16a49dfb5f7f45624c9551751d14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_243925e72f165f6a01a75a78ffd43ec4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3778f739fa3fe8eb786f25a16339e47f
publicationDate 2022-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber TW-202220661-A
titleOfInvention Improved pharmaceutical formulations comprising pi3k inhibitors
abstract The invention relates to an oral pharmaceutical formulation endowed with pH independent improved solubility comprising as active ingredient a PI3K inhibitor, such as the pyrimidine derivative 5-(7- (methylsulfonyl) -2-morpholino -6,7- dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrimidin-2-amine.
priorityDate 2020-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409623724
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID49784945

Total number of triples: 27.